GovIntel / MA / COGNITO THERAPEUTICS GROUP, INC.

COGNITO THERAPEUTICS GROUP, INC.

Government contractor · Cambridge, MA

UEIH7Z3B8BU47J4
CAGE15Q77
SizeSmall business
SAM statusActive
Established2025

About COGNITO THERAPEUTICS GROUP, INC.

Cognito Therapeutics is developing non-invasive neuroprotective therapies, specifically Spectris, aimed at improving the lives of patients with neurodegenerative diseases such as Alzheimer’s by evoking specific brain wave activity. The company is focused on clinical research and has received FDA Breakthrough Device Designation for its treatment.

Development of non-invasive neuroprotective therapiesDesign and delivery of audiovisual stimulation to evoke brain wave activityConducting clinical studies for Alzheimer’s disease treatmentExploring treatment across multiple neurodegenerative diseases

Is this your company?

Claim COGNITO THERAPEUTICS GROUP, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim COGNITO THERAPEUTICS GROUP, INC. & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.